What is the process of HDL (High-Density Lipoprotein) creation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HDL Creation and Synthesis

HDL is created through two primary pathways: hepatic and intestinal secretion of lipid-poor apolipoprotein A-I particles, which then acquire cholesterol and phospholipids from peripheral tissues and other lipoproteins to form mature HDL particles. 1

Primary Sites of HDL Synthesis

Nascent HDL particles are secreted by the liver and intestine (via lymph) as lipid-poor or lipid-free apolipoprotein A-I (apo A-I) particles. 2, 3 These newly secreted particles represent the initial form of HDL before they undergo maturation in the circulation.

  • The liver is the predominant source of apo A-I, the principal protein constituent of HDL 2
  • The intestine contributes nascent HDL particles that enter the circulation through the lymphatic system 2, 3
  • These nascent particles are initially small, lipid-poor, and protein-rich compared to mature HDL 2

Maturation Process: From Nascent to Mature HDL

The conversion of nascent HDL into mature, functional particles occurs through a stepwise lipidation process in the circulation:

Step 1: Initial Lipid Acquisition via ABCA1

Lipid-free or lipid-poor apo A-I particles interact with ATP-binding cassette transporter A1 (ABCA1) on cell membranes to acquire phospholipids and cholesterol, forming nascent discoidal HDL particles. 1, 4

  • ABCA1 mediates the efflux of cellular phospholipid and cholesterol to apo A-I 4
  • This interaction creates discoidal HDL particles approximately 10 nm in diameter 4
  • Two apo A-I molecules typically stabilize these discoidal particles in an anti-parallel, double-belt conformation around the edge of the disc 4

Step 2: Cholesterol Esterification by LCAT

The enzyme lecithin:cholesterol acyltransferase (LCAT) converts free cholesterol on nascent HDL into cholesteryl esters, which migrate to the particle core, transforming discoidal HDL into spherical, mature HDL particles. 2, 3

  • LCAT transfers a fatty acid moiety from phosphatidylcholine to cholesterol 2
  • This esterification creates a hydrophobic core of cholesteryl esters 2
  • The formation of this core facilitates the creation of stable, spherical HDL particles 2

Step 3: Additional Lipid Acquisition and Particle Growth

HDL particles continue to acquire lipids through multiple mechanisms, growing in size and transitioning from smaller, denser HDL3 to larger, more lipid-rich HDL2 subfractions. 2

  • HDL acquires surface components (phospholipids, free cholesterol, and apolipoproteins) from triglyceride-rich lipoproteins during their lipolysis by lipoprotein lipase 2, 3
  • Scavenger receptor class B type I (SR-BI) facilitates bidirectional cholesterol flux between cells and HDL 1
  • HDL2 particles are larger and more lipid-rich, while HDL3 particles are smaller, denser, and relatively protein-rich 2

Secondary Sources of HDL Components

HDL also acquires components from the catabolism of triglyceride-rich lipoproteins (chylomicrons and VLDL) during their hydrolysis by lipoprotein lipase. 2, 3

  • When chylomicrons and VLDL are hydrolyzed in capillary beds, surface components (phospholipids, free cholesterol, and C apolipoproteins) are released 5
  • These surface remnants contribute to HDL formation and remodeling 2
  • The majority of apolipoproteins C (CI, CII, CIII) and apolipoprotein E on VLDL are actually acquired from HDL after VLDL enters the plasma 5

HDL Composition

The mature HDL particle consists of approximately 50% lipid and 50% protein by weight 2:

  • Major lipid components: Phosphatidylcholine (primary), sphingomyelin (secondary), cholesterol, and cholesteryl esters 2
  • Major protein component: Apolipoprotein A-I is the principal protein 2, 5
  • Associated enzymes and proteins: LCAT, paraoxonase 1 (PON1), cholesteryl ester transfer protein (CETP) 5

Clinical Relevance

The HDL2 subfraction, which is larger and more lipid-rich, shows the strongest inverse relationship with coronary artery disease risk. 2 Understanding HDL synthesis is critical because:

  • Genetic variations in apo A-I can result in larger but less stable HDL particles and decreased circulating HDL levels 5
  • Hepatic lipase and endothelial lipase are intimately involved in HDL metabolism and remodeling 5
  • In hypertriglyceridemic states, increased hepatic triglyceride lipase (HTGL) activity can contribute to low HDL-C levels by converting larger HDL2 to smaller HDL3 particles 5

Common Pitfalls

Do not confuse HDL synthesis with reverse cholesterol transport—HDL creation is the initial formation of the particle, while reverse cholesterol transport is the functional process by which mature HDL removes cholesterol from peripheral tissues and delivers it to the liver. 5, 6 The synthesis process focuses on particle assembly, whereas reverse cholesterol transport describes HDL's primary atheroprotective function after formation.

References

Research

High-density lipoprotein synthesis and metabolism (Review).

Molecular medicine reports, 2015

Research

High-density lipoproteins: biochemical and metabolic factors.

The American journal of cardiology, 1983

Research

HDL metabolism and its role in lipid transport.

European heart journal, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Role of HDL in Cardiovascular Health

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.